[Indication] Treatment of chronic hepatitis with evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease(This indication is based on histological, virological,biochemical, and serological responses in patients with HBeAg+ and HBeAg- chronic hepatitis B with compensated liver function, and with clinical evidence of lamivudine-resistant hepatitis B virus with either compensated or decompensated liver function.) [Active Ingredients] Adefovir dipivoxil